Effects of ulipristal: A Synthesis of Findings from 25 Studies
- Home
- Effects of ulipristal
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of ulipristal: A Synthesis of Findings from 25 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
The studies examined the effects of zolpidem, a non-benzodiazepine hypnotic, on sleep and cognitive function. 3 found that zolpidem 20 mg, when taken before bed, significantly improved sleep quality compared to a placebo. Importantly, unlike another hypnotic drug, flunitrazepam, zolpidem did not cause any noticeable impairments in cognitive performance or daytime wakefulness. This suggests that zolpidem may have fewer side effects compared to other sleep medications. 19 further explored this idea by comparing the effects of zolpidem-MR, a modified-release formulation of zolpidem, to placebo and flurazepam in elderly volunteers. The results showed that zolpidem-MR did not affect cognitive function, unlike flurazepam, while still promoting good sleep quality. 14 also found that zolpidem was more effective than triazolam, another hypnotic drug, in improving sleep quality without causing significant morning sleepiness. Additionally, 22 compared zolpidem with zaleplon, another non-benzodiazepine hypnotic, for their effectiveness and safety in treating primary insomnia. The results showed that both drugs were effective in shortening sleep latency, indicating their potential for helping people fall asleep faster. However, the studies did not directly compare the side effects of these two drugs. 7 compared zolpidem with triazolam on memory, psychomotor performance, and postural sway. The study found that both drugs impaired memory and psychomotor performance, but the effects were of short duration. 11 investigated the effects of zolpidem and several other sedatives and hypnotics, including alcohol, on human performance and memory. This study demonstrated that zolpidem significantly impaired various cognitive and psychomotor skills, while other agents had lesser effects. However, the study suggested that zolpidem might impair memory less than diazepam, another benzodiazepine. 25 conducted a systematic review of zolpidem use by older adults. The review showed that zolpidem is generally effective for treating insomnia in older adults, reducing sleep latency, improving sleep efficiency, and having a low risk of daytime sleepiness or memory impairments. However, it also acknowledged the need for further research on the long-term effects of zolpidem in this population. 4 investigated the dose-dependent effects of zolpidem on sleep in healthy individuals. This study found that zolpidem was effective in decreasing sleep latency and increasing total sleep time at doses as low as 5 mg. Higher doses (20 mg) were associated with a decrease in REM sleep. 8 compared the effects of zolpidem, triazolam, and temazepam on learning, recall, and performance. This study found that zolpidem had similar effects to other benzodiazepine hypnotics, including impairing cognitive performance and increasing drowsiness. 15 examined the residual effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance. This study found that zolpidem had less residual effect on sleepiness and psychomotor function the next morning compared to zopiclone, suggesting that it may be less likely to affect daytime alertness. 12 investigated the effects of caffeine on zolpidem's effects. This study found that caffeine did not counteract the sedative effects of zolpidem. 1 reviewed the use of zolpidem in managing sleep disorders. The review highlighted its effectiveness in reducing sleep onset latency and improving overall sleep quality, but also acknowledged the need for further research on its effects on tolerance and dependence. 17 investigated the acute neurophysiological effects of zolpidem using electroencephalogram (EEG). The study found that zolpidem affected brain activity similar to other sedatives, but it also observed an unexpected increase in a specific EEG component, P2 amplitude, suggesting further investigation is needed on its specific effects. 5 investigated the interaction between zolpidem and alcohol on cognitive and psychomotor function. The study found that zolpidem and alcohol had additive effects on performance impairment, indicating that the combination of these substances could have a greater impact on cognitive performance than either substance alone. 20 investigated the effects of zolpidem on GABA levels in the thalamus, a brain region crucial for sleep regulation. The study found that a therapeutic dose of zolpidem reduced GABA levels in the thalamus, suggesting that its effects on sleep might be mediated by changes in neurotransmitter activity. 18 investigated the residual effects of zolpidem-MR on psychomotor and cognitive function in young healthy volunteers. This study found that zolpidem-MR did not significantly impair cognitive function, unlike flurazepam, while still improving sleep quality. 13 compared the duration of residual effects of zaleplon and zolpidem. This study found that zaleplon had no residual effects when administered 2 hours before waking, whereas zolpidem still had residual effects up to 5 hours after administration. 10 investigated the effects of zolpidem, triazolam, and placebo on sleep quality the night before surgery. This study found that zolpidem and triazolam were equally effective in improving sleep quality and were well tolerated. 21 investigated the effects of zolpidem and zopiclone on driving performance in older drivers. This study found that both drugs impaired driving performance similarly, suggesting that these medications can negatively impact driving skills, particularly in older adults. 9 evaluated the efficacy and safety of zolpidem in treating short-term insomnia. This study found that zolpidem was more effective than placebo in reducing sleep latency, improving sleep quality, and was well tolerated. 6 investigated the effects of different doses of zolpidem on sleep patterns in healthy individuals. The study found that zolpidem had a minimal effect on sleep architecture and that it did not significantly disrupt sleep stages. 16 reported on a multicenter study of zolpidem's effectiveness in treating various sleep disorders. The study found that zolpidem was highly effective and safe in treating different types of insomnia. 24 explored the potential for zolpidem to induce mania. While the study acknowledged that such cases are rare, it highlighted the importance of considering the potential for zolpidem to cause stimulant effects in specific populations.
Benefits and Risks
Benefit Summary
Zolpidem can be an effective treatment for insomnia, helping people fall asleep faster and improving overall sleep quality. 3 Studies suggest that zolpidem is generally well-tolerated and does not cause significant cognitive impairments or daytime sleepiness, compared to other hypnotic medications. 19 14 22 9 16
Risk Summary
As with any medication, zolpidem carries potential risks. While zolpidem appears to have fewer side effects than some other hypnotic drugs, it can still impair cognitive function, particularly when combined with alcohol. 5 11 21 8 15 It's also important to be aware of the potential for dependence and withdrawal symptoms. 1 Additionally, zolpidem may cause a decrease in REM sleep, which can have implications for dreaming and memory consolidation. 4 6 24 While rare, some people may experience stimulant effects or even manic episodes while taking zolpidem. 24
Comparison Across Studies
Commonalities Across Studies
The studies generally agree that zolpidem can be effective in improving sleep quality, particularly in reducing sleep latency and increasing total sleep time. 3 19 14 22 4 6 9 16 10 Most studies also agree that zolpidem's side effects appear to be less severe than those of other hypnotic drugs, particularly in terms of cognitive impairment and daytime sleepiness. 3 19 14 15 25 9 13
Differences Across Studies
Some differences emerge in terms of the specific effects of zolpidem, particularly in relation to memory and other cognitive functions. Some studies suggest that zolpidem may have a more pronounced effect on memory than other hypnotic drugs, particularly when it comes to delayed recall. 7 11 Other studies show that zolpidem can impair psychomotor performance and alertness, even when administered at lower doses. 5 21 8 15 The impact of zolpidem on REM sleep also varies, with some studies suggesting a decrease in REM sleep at higher doses. 4 6 The duration of zolpidem's effects also appears to vary, with some studies showing residual effects up to 5 hours after administration. 13 3
Consistency and Discrepancies in Findings
While there is general consensus that zolpidem can be an effective treatment for insomnia, there are some inconsistencies regarding its impact on cognitive function and the duration of its effects. Some studies suggest that zolpidem may have a greater impact on memory than other hypnotics. 7 11 Additionally, the duration of zolpidem's effects appears to vary depending on the dosage and formulation. 13 3 19 Further research is needed to clarify these inconsistencies and to understand the nuances of zolpidem's effects on cognitive function and alertness.
Considerations for Real-World Application
Zolpidem can be a valuable tool for treating insomnia, particularly for individuals struggling with difficulty falling asleep. 3 19 14 22 9 16 10 However, it's crucial to use it responsibly and according to your doctor's instructions. Avoid driving or operating machinery after taking zolpidem, as it can impair your judgment and reaction time. 21 5 Be aware of the potential for dependence and withdrawal symptoms, and discuss any concerns with your doctor. 1 Also, keep in mind that zolpidem may not be suitable for everyone, especially those with certain medical conditions or who are pregnant or breastfeeding.
Limitations of Current Research
While the research provides valuable insights into the effects of zolpidem, there are some limitations. Many studies focus on short-term effects, and long-term studies are needed to better understand the chronic effects of zolpidem use. 25 The studies primarily examine healthy individuals, and more research is needed on the effects of zolpidem in specific populations, such as older adults and people with co-existing conditions. 2 25 15 Additionally, more research is needed to clarify the interaction between zolpidem and other medications or substances, including alcohol. 5 12
Future Directions for Research
Further research is needed to better understand the long-term effects of zolpidem, particularly its impact on cognitive function and the potential for dependence. 25 1 More research is also needed to investigate the effects of zolpidem in specific populations, such as older adults and individuals with co-existing conditions. 2 25 15 Additional research is needed to examine the potential for zolpidem to induce stimulant effects in some individuals. 24
Conclusion
Zolpidem appears to be an effective treatment for insomnia, offering potential benefits in helping people fall asleep faster and improving sleep quality. 3 19 14 22 4 9 16 10 While it offers advantages over some other hypnotic medications, it's crucial to be aware of its potential risks and to use it responsibly. 5 11 21 8 15 1 24 Consult with your doctor to determine if zolpidem is the right treatment option for you. 17 20 18 13 25 2 6 4 1 12
Benefit Keywords
Risk Keywords
Article Type
Author: LavoisyJ, ZivkovicB, BenavidesJ, PerraultG H, RobertP
Language : French
Author: ScharfM B, MaylebenD W, KaffemanM, KrallR, OchsR
Language : English
Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.
Author: BensimonG, ForetJ, WarotD, LacomblezL, ThiercelinJ F, SimonP
Language : English
Author: MerlottiL, RoehrsT, KoshorekG, ZorickF, LamphereJ, RothT
Language : English
Author: WilkinsonC J
Language : English
Author: BloisR, GaillardJ M, AttaliP, CoquelinJ P
Language : English
Author: BerlinI, WarotD, HerguetaT, MolinierP, BagotC, PuechA J
Language : English
Author: RushC R, GriffithsR R
Language : English
Author: DockhornR J, DockhornD W
Language : English
Author: MorganP J, ChapadosR, ChungF F, GauthierM, KnoxJ W, Le LorierJ
Language : English
Author: MattilaM J, VanakoskiJ, KalskaH, SeppäläT
Language : English
Language : English
Author: DanjouP, PatyI, FruncilloR, WorthingtonP, UnruhM, CevallosW, MartinP
Language : English
Author: KannoO, SasakiT, WatanabeH, TakazawaS, NakagomeK, NakajimaT, IchikawaI, AkahoR, SuzukiM
Language : English
Author: UchiumiM, IsawaS, SuzukiM, MurasakiM
Language : English
Author: AleksandrovskiĭIu A, AndrosovaV V
Language : Russian
Author: LucchesiLígia M, BragaNadia I de O, ManzanoGilberto M, PompéiaSabine, TufikSergio
Language : English
Author: BlinOlivier, MicallefJoëlle, AudebertChristine, LegangneuxEric
Language : English
Author: HindmarchIan, LegangneuxEric, StanleyNeil, EmegboSteve, DawsonJean
Language : English
Author: LicataStephanie C, JensenJ Eric, PenetarDavid M, PrescotAndrew P, LukasScott E, RenshawPerry F
Language : English
Author: BoccaMarie-Laure, MarieSullivan, Lelong-BoulouardVéronique, BertranFrançoise, CouqueColette, DesfemmesTsellina, BerthelonCatherine, AmatoJean-Noel, MoessingerMichèle, Paillet-LoilierMagalie, CoquerelAntoine, DenisePierre
Language : English
Author: HuangYu-Shu, HsuShih-Chieh, LiuShen-Ing, ChenChih-Ken
Language : English
Author: StranksElizabeth K, CroweSimon F
Language : English
Author: SabeM, KashefH, GironiC, SentissiO
Language : English
Author: MachadoFlávio V, LouzadaLuciana L, CrossNathan E, CamargosEinstein F, Dang-VuThien Thanh, NóbregaOtávio T
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.